1
|
Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.
|
Arterioscler Thromb Vasc Biol
|
1999
|
2.75
|
2
|
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
|
Nat Genet
|
1994
|
2.65
|
3
|
Conjugation deficient E. coli K12 F- mutants with heptose-less lipopolysaccharide.
|
Mol Gen Genet
|
1976
|
2.22
|
4
|
Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis.
|
Ann Intern Med
|
1994
|
2.11
|
5
|
Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.
|
Circ Res
|
2001
|
1.91
|
6
|
Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2000
|
1.89
|
7
|
Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.79
|
8
|
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.70
|
9
|
Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
|
Arch Neurol
|
1998
|
1.67
|
10
|
Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
|
J Clin Invest
|
1994
|
1.56
|
11
|
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
|
J Lipid Res
|
2001
|
1.43
|
12
|
Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.
|
J Biol Chem
|
1993
|
1.41
|
13
|
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients.
|
Atherosclerosis
|
1996
|
1.40
|
14
|
Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice.
|
Atherosclerosis
|
1999
|
1.33
|
15
|
Exact localization of the familial dysbetalipoproteinemia associated HpaI restriction site in the promoter region of the APOC1 gene.
|
Biochem Biophys Res Commun
|
1988
|
1.31
|
16
|
Apolipoprotein e4 allele and cognitive decline in elderly men.
|
BMJ
|
1994
|
1.31
|
17
|
Protection from obesity in mice lacking the VLDL receptor.
|
Arterioscler Thromb Vasc Biol
|
2001
|
1.28
|
18
|
Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice.
|
Atherosclerosis
|
1994
|
1.28
|
19
|
In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake.
|
Diabetes
|
2001
|
1.25
|
20
|
Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.
|
J Clin Invest
|
1998
|
1.23
|
21
|
Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.
|
J Clin Invest
|
1997
|
1.20
|
22
|
Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure.
|
Arterioscler Thromb Vasc Biol
|
1996
|
1.20
|
23
|
Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
|
J Biol Chem
|
1993
|
1.19
|
24
|
Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death.
|
Cell Death Differ
|
2006
|
1.15
|
25
|
A rapid micromethod for apolipoprotein E phenotyping directly in serum.
|
J Lipid Res
|
1987
|
1.15
|
26
|
Characterization of an Escherichia coli K-12 F-Con-mutant.
|
J Bacteriol
|
1976
|
1.13
|
27
|
Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1.
|
Diabetes
|
2001
|
1.10
|
28
|
Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice.
|
Diabetologia
|
2005
|
1.07
|
29
|
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
|
Hum Mutat
|
1994
|
1.07
|
30
|
Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
|
J Biol Chem
|
1999
|
1.06
|
31
|
Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.
|
BMJ
|
1995
|
1.06
|
32
|
Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study.
|
Atherosclerosis
|
1999
|
1.04
|
33
|
Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding.
|
Atherosclerosis
|
1995
|
1.03
|
34
|
The mouse low density lipoprotein receptor gene: cDNA sequence and exon-intron structure.
|
Biochem Biophys Res Commun
|
1993
|
1.03
|
35
|
Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion.
|
J Biol Chem
|
2001
|
1.01
|
36
|
Stimulation of the LDL receptor activity in the human hepatoma cell line Hep G2 by high-density serum fractions.
|
Biochim Biophys Acta
|
1986
|
1.01
|
37
|
Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.01
|
38
|
Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins.
|
Biochem Biophys Res Commun
|
1992
|
1.01
|
39
|
Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2000
|
1.01
|
40
|
Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.
|
Neurosci Lett
|
1998
|
1.01
|
41
|
Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice.
|
Arterioscler Thromb Vasc Biol
|
2001
|
1.01
|
42
|
In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
|
J Clin Invest
|
1996
|
1.00
|
43
|
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
|
Biochem Pharmacol
|
2010
|
1.00
|
44
|
Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.
|
J Clin Invest
|
1986
|
0.99
|
45
|
Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.
|
J Clin Invest
|
1991
|
0.99
|
46
|
Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study.
|
J Neural Transm Suppl
|
1998
|
0.99
|
47
|
The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival.
|
Ann Neurol
|
1995
|
0.98
|
48
|
Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice.
|
Diabetologia
|
2006
|
0.98
|
49
|
Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis.
|
Atherosclerosis
|
1998
|
0.97
|
50
|
Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E.
|
J Hepatol
|
2001
|
0.96
|
51
|
White adipose tissue: getting nervous.
|
J Neuroendocrinol
|
2003
|
0.96
|
52
|
Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis.
|
J Biol Chem
|
2000
|
0.95
|
53
|
LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice.
|
J Lipid Res
|
2000
|
0.95
|
54
|
Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
|
Biochem J
|
1997
|
0.94
|
55
|
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
|
J Thromb Haemost
|
2005
|
0.94
|
56
|
Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice.
|
J Lipid Res
|
2000
|
0.94
|
57
|
Living up to a name: the role of the VLDL receptor in lipid metabolism.
|
Curr Opin Lipidol
|
2001
|
0.94
|
58
|
Severe learning deficits in apolipoprotein E-knockout mice in a water maze task.
|
Brain Res
|
1997
|
0.94
|
59
|
Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages.
|
Biochem J
|
1996
|
0.93
|
60
|
Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
|
Arterioscler Thromb Vasc Biol
|
1996
|
0.93
|
61
|
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
|
Circulation
|
2001
|
0.93
|
62
|
Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.
|
Circ Res
|
2000
|
0.92
|
63
|
Regulation of low density lipoprotein receptor activity in primary cultures of human hepatocytes by serum lipoproteins.
|
Hepatology
|
1987
|
0.92
|
64
|
The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2.
|
Biochem J
|
1990
|
0.92
|
65
|
Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
|
J Neuroendocrinol
|
2008
|
0.92
|
66
|
ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study.
|
Arterioscler Thromb
|
1994
|
0.91
|
67
|
The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
|
Atherosclerosis
|
1996
|
0.91
|
68
|
The mouse apolipoprotein C1 gene: structure and expression.
|
Genomics
|
1993
|
0.91
|
69
|
Gut-brain axis: regulation of glucose metabolism.
|
J Neuroendocrinol
|
2006
|
0.91
|
70
|
Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.
|
Alzheimer Dis Assoc Disord
|
1998
|
0.91
|
71
|
Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing.
|
J Lipid Res
|
1995
|
0.90
|
72
|
Evolutionary conservation of the mouse apolipoprotein e-c1-c2 gene cluster: structure and genetic variability in inbred mice.
|
Genomics
|
1993
|
0.90
|
73
|
Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.
|
Br J Pharmacol
|
2014
|
0.90
|
74
|
ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels.
|
Genet Epidemiol
|
2000
|
0.90
|
75
|
Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia.
|
Atherosclerosis
|
2000
|
0.89
|
76
|
Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging.
|
Lab Invest
|
2001
|
0.89
|
77
|
Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
|
Biochem J
|
1999
|
0.88
|
78
|
Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice.
|
Arterioscler Thromb Vasc Biol
|
2001
|
0.87
|
79
|
Structure and expression of the mouse apolipoprotein C2 gene.
|
Genomics
|
1993
|
0.87
|
80
|
Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.87
|
81
|
Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.
|
J Biol Chem
|
1989
|
0.86
|
82
|
The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2.
|
Biochim Biophys Acta
|
1991
|
0.86
|
83
|
Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study.
|
Stroke
|
2001
|
0.86
|
84
|
In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
|
J Biol Chem
|
1996
|
0.86
|
85
|
The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice.
|
Biochemistry
|
2001
|
0.86
|
86
|
Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice.
|
Diabetologia
|
2006
|
0.86
|
87
|
Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism.
|
Eur J Clin Invest
|
1998
|
0.86
|
88
|
Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
|
Biochem J
|
1997
|
0.86
|
89
|
Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.
|
J Lipid Res
|
1990
|
0.86
|
90
|
Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.
|
Atherosclerosis
|
1998
|
0.85
|
91
|
Increased response to cholesterol feeding in apolipoprotein C1-deficient mice.
|
Biochem J
|
1995
|
0.85
|
92
|
Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver.
|
Hepatology
|
1996
|
0.85
|
93
|
Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study.
|
Arterioscler Thromb Vasc Biol
|
1997
|
0.85
|
94
|
Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
|
J Clin Invest
|
1996
|
0.85
|
95
|
Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.85
|
96
|
Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment.
|
J Biol Chem
|
1993
|
0.85
|
97
|
Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis.
|
Int J Tissue React
|
2000
|
0.84
|
98
|
Effective generation of very low density lipoprotein receptor transgenic mice by overlapping genomic DNA fragments: high testis expression and disturbed spermatogenesis.
|
Transgenic Res
|
2001
|
0.84
|
99
|
Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models.
|
Curr Atheroscler Rep
|
1999
|
0.84
|
100
|
The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.
|
Br J Pharmacol
|
2009
|
0.84
|
101
|
Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a).
|
Atherosclerosis
|
1991
|
0.84
|
102
|
APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome.
|
Diabetes Obes Metab
|
2014
|
0.84
|
103
|
Dynamics of insulin signalling in liver during hyperinsulinemic euglycaemic clamp conditions in vivo and the effects of high-fat feeding in male mice.
|
Arch Physiol Biochem
|
2007
|
0.84
|
104
|
The T705I mutation of the low density lipoprotein receptor gene (FH Paris-9) does not cause familial hypercholesterolemia.
|
Hum Genet
|
1997
|
0.83
|
105
|
High fat diet induced hepatic insulin resistance is not related to changes in hypothalamic mRNA expression of NPY, AgRP, POMC and CART in mice.
|
Peptides
|
2005
|
0.83
|
106
|
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.
|
Atherosclerosis
|
1990
|
0.83
|
107
|
Macrophage specific overexpression of the human macrophage scavenger receptor in transgenic mice, using a 180-kb yeast artificial chromosome, leads to enhanced foam cell formation of isolated peritoneal macrophages.
|
Atherosclerosis
|
1999
|
0.83
|
108
|
The effect of apolipoprotein(a)-, apolipoprotein E-, and apolipoprotein A4- polymorphisms on quantitative lipoprotein(a) concentrations.
|
Twin Res
|
2000
|
0.83
|
109
|
Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
|
Int J Tissue React
|
2000
|
0.83
|
110
|
Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.
|
Atherosclerosis
|
1996
|
0.83
|
111
|
Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4.
|
Biochem Biophys Res Commun
|
1989
|
0.82
|
112
|
Mutational and genetic origin of LDL receptor gene mutations detected in both Belgian and Dutch familial hypercholesterolemics.
|
Hum Genet
|
1997
|
0.82
|
113
|
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
|
Atherosclerosis
|
1998
|
0.82
|
114
|
Absence of mutations in the promoter region of the low density lipoprotein receptor gene in a large number of familial hypercholesterolaemia patients as revealed by denaturing gradient gel electrophoresis.
|
Hum Genet
|
1992
|
0.81
|
115
|
Identification of a double mutation in the low-density lipoprotein receptor gene causing familial hypercholesterolemia.
|
Clin Genet
|
1996
|
0.81
|
116
|
Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.
|
J Thromb Haemost
|
2014
|
0.81
|
117
|
Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
|
Am J Med Genet
|
2002
|
0.81
|
118
|
Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
|
Biochem J
|
2000
|
0.81
|
119
|
Rearrangements in the LDL receptor gene in Dutch familial hypercholesterolemic patients and the presence of a common 4 kb deletion.
|
Atherosclerosis
|
1990
|
0.81
|
120
|
Analysis of the structure and function relationship of the human apolipoprotein E in vivo, using adenovirus-mediated gene transfer.
|
FASEB J
|
2001
|
0.81
|
121
|
Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle.
|
Atherosclerosis
|
1998
|
0.81
|
122
|
Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.81
|
123
|
Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. A comparison of two cholesterol-lowering diets.
|
Atherosclerosis
|
1982
|
0.80
|
124
|
Identification of differentially regulated genes in mildly hyperlipidemic ApoE3-Leiden mice by use of serial analysis of gene expression.
|
Arterioscler Thromb Vasc Biol
|
2001
|
0.80
|
125
|
Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor.
|
J Biol Chem
|
2001
|
0.80
|
126
|
Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice.
|
Arterioscler Thromb Vasc Biol
|
2002
|
0.80
|
127
|
Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages.
|
Arterioscler Thromb
|
1991
|
0.80
|
128
|
An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins.
|
J Biol Chem
|
1999
|
0.80
|
129
|
Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.80
|
130
|
Not the mature 56 kDa lipoprotein lipase protein but a 37 kDa protein co-purifying with the lipase mediates the binding of low density lipoproteins to J774 macrophages.
|
Biochem J
|
1998
|
0.80
|
131
|
Physical activity modulates the effect of a lipoprotein lipase mutation (D9N) on plasma lipids and lipoproteins.
|
Clin Genet
|
1999
|
0.79
|
132
|
Familial dysbetalipoproteinemic subjects with the E3/E2 phenotype exhibit an E2 isoform with only one cysteine residue.
|
Clin Genet
|
1987
|
0.79
|
133
|
Lipoprotein profiles in a family with two mutants of apolipoprotein E: possible association with hypertriglyceridaemia but not with dysbetalipoproteinaemia.
|
Clin Sci (Lond)
|
1994
|
0.79
|
134
|
Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle.
|
Arterioscler Thromb
|
1992
|
0.79
|
135
|
Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
|
Arterioscler Thromb Vasc Biol
|
1998
|
0.79
|
136
|
Apolipoprotein E phenotype is not related to late-life depression in a population-based sample.
|
Soc Psychiatry Psychiatr Epidemiol
|
1998
|
0.79
|
137
|
Preferential association of apolipoprotein E Leiden with very low density lipoproteins of human plasma.
|
J Lipid Res
|
1993
|
0.79
|
138
|
Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility.
|
Diabet Med
|
2014
|
0.79
|
139
|
Mice expressing only the mutant APOE3Leiden gene show impaired VLDL secretion.
|
Arterioscler Thromb Vasc Biol
|
2001
|
0.79
|
140
|
Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patient.
|
Eur J Clin Invest
|
1984
|
0.79
|
141
|
Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins.
|
Atherosclerosis
|
1994
|
0.78
|
142
|
Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.78
|
143
|
Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in The Netherlands.
|
Clin Genet
|
2000
|
0.78
|
144
|
Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
|
Atherosclerosis
|
1998
|
0.78
|
145
|
Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
|
J Clin Invest
|
1994
|
0.78
|
146
|
Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase.
|
J Lipid Res
|
1997
|
0.78
|
147
|
Regulation of cholesterol metabolism in the liver in vivo and in vitro.
|
Biochem Soc Trans
|
1987
|
0.78
|
148
|
Effects of high fat diet on the Basal activity of the hypothalamus-pituitary-adrenal axis in mice: a systematic review.
|
Horm Metab Res
|
2011
|
0.78
|
149
|
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
|
Atherosclerosis
|
2000
|
0.78
|
150
|
Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations.
|
J Lipid Res
|
1988
|
0.78
|
151
|
Characterisation of the LDL receptor in Epstein-Barr virus transformed lymphocytes.
|
Biochim Biophys Acta
|
1990
|
0.77
|
152
|
Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.
|
Arterioscler Thromb
|
1994
|
0.77
|
153
|
Efficient targeting of adenoviral vectors to integrin positive vascular cells utilizing a CAR-cyclic RGD linker protein.
|
Biochem Biophys Res Commun
|
2005
|
0.77
|
154
|
A novel V415A mutation in exon 9 of the low density lipoprotein receptor gene causing familial hypercholesterolemia.
|
Clin Genet
|
1997
|
0.77
|
155
|
In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
|
J Lipid Res
|
1999
|
0.77
|
156
|
Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members.
|
Hum Mol Genet
|
1995
|
0.77
|
157
|
Effect of insulin resistance, apoE2 allele, and smoking on combined hyperlipidemia.
|
Arterioscler Thromb
|
1994
|
0.77
|
158
|
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
|
Arzneimittelforschung
|
1998
|
0.77
|
159
|
Association of EGF and LDL receptors with the cytoskeleton of cultured keratinocytes.
|
Cell Biol Int Rep
|
1990
|
0.77
|
160
|
Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach.
|
Curr Opin Lipidol
|
1996
|
0.77
|
161
|
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice.
|
J Hepatol
|
2000
|
0.77
|
162
|
Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE*3-Leiden transgenic mice.
|
Atherosclerosis
|
2001
|
0.77
|
163
|
Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle.
|
Atherosclerosis
|
2001
|
0.77
|
164
|
The apolipoprotein C2-linked (Acl) gene: a new gene within the mouse apolipoprotein e-c1-c2 gene cluster.
|
Genomics
|
1994
|
0.77
|
165
|
Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.
|
J Lipid Res
|
1998
|
0.77
|
166
|
The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome.
|
Eur J Clin Nutr
|
2010
|
0.76
|
167
|
Use of transgenic mice to study the role of apolipoprotein E in lipid metabolism and atherosclerosis.
|
Int J Tissue React
|
2000
|
0.76
|
168
|
Similar response to simvastatin in patients heterozygous for familial hypercholesterolemia with mRNA negative and mRNA positive mutations.
|
Atherosclerosis
|
1998
|
0.76
|
169
|
Rare apolipoprotein E variant cosegregating with a unique APOE-C1-C2 haplotype in a normolipidemic family.
|
Hum Hered
|
1988
|
0.76
|
170
|
Serum lipoproteins in cholesterol-fed pigs after partial ileal bypass.
|
Lab Anim
|
1985
|
0.76
|
171
|
Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.76
|
172
|
An acceptor splice site mutation in intron 16 of the low density lipoprotein receptor gene leads to an elongated, internalization defective receptor.
|
Atherosclerosis
|
1993
|
0.76
|
173
|
Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase.
|
Arterioscler Thromb Vasc Biol
|
1997
|
0.76
|
174
|
Apolipoprotein epsilon 4 and coronary artery disease.
|
Lancet
|
1992
|
0.75
|
175
|
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.
|
Heart
|
2002
|
0.75
|
176
|
Apolipoprotein E phenotype and blood pressure.
|
Lancet
|
1994
|
0.75
|
177
|
Fibrinogen genes and peripheral arterial disease.
|
Lancet
|
1992
|
0.75
|
178
|
An additional MspI RFLP at the human hepatic lipase (HL) gene locus.
|
Nucleic Acids Res
|
1990
|
0.75
|
179
|
Low-density lipoproteins are degraded in HepG2 cells with low efficiency.
|
Biochem J
|
1993
|
0.75
|
180
|
The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system.
|
Br J Pharmacol
|
2013
|
0.75
|
181
|
Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.75
|
182
|
Treatment of E2E2 homozygous familial dysbetalipoproteinemic subjects with gemfibrozil does not enhance the binding of their d < 1.019 lipoprotein fraction to the low-density lipoprotein receptor.
|
Metabolism
|
1993
|
0.75
|
183
|
Identification of a splice-site mutation in the low density lipoprotein receptor gene by denaturing gradient gel electrophoresis.
|
Hum Genet
|
1993
|
0.75
|
184
|
The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: results of a Dutch twin study.
|
Hum Genet
|
1993
|
0.75
|
185
|
The effect of tibolone on the lipoprotein profile of postmenopausal women with type III hyperlipoproteinemia.
|
J Intern Med
|
2002
|
0.75
|
186
|
Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
|
Diabetologia
|
2001
|
0.75
|
187
|
Effects of oral contraceptives on lipid metabolism.
|
Am J Obstet Gynecol
|
1990
|
0.75
|
188
|
Regulation of low-density lipoprotein receptor expression during keratinocyte differentiation.
|
J Invest Dermatol
|
1991
|
0.75
|
189
|
Variability in cholesterol content in serum and aortic tissue in apolipoprotein E-deficient mice is comparable in inbred (129/Sv) and outbred (mixed 129/Sv and C57BL/6) mice.
|
Atherosclerosis
|
1995
|
0.75
|
190
|
Elevated levels of chylomicron- and VLDL-remnants leads to atherosclerosis in apoE transgenic mice.
|
Z Gastroenterol
|
1996
|
0.75
|
191
|
Identification of three new mutations of the low density lipoprotein receptor gene in Dutch familial hypercholesterolemic patients.
|
Hum Mutat
|
1998
|
0.75
|
192
|
Plasma plasminogen activator inhibitor-1 level is not regulated by the hepatic low-density lipoprotein receptor-related protein.
|
J Thromb Haemost
|
2007
|
0.75
|
193
|
Immunological discrimination between the human apolipoprotein E2(Arg158----Cys) and E3 isoforms.
|
J Lipid Res
|
1992
|
0.75
|
194
|
The effect of dietary linoleic acid and pectin on lipoprotein and apolipoprotein A1 concentrations in rhesus monkeys.
|
Ann Nutr Metab
|
1984
|
0.75
|
195
|
Detection of allele-specific transcripts by the polymerase chain reaction (AST-PCR).
|
Biochem Biophys Res Commun
|
1991
|
0.75
|
196
|
Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease.
|
J Neurol
|
1996
|
0.75
|
197
|
The 13th annual meeting of the European Lipoprotein Club.
|
Arterioscler Thromb
|
1991
|
0.75
|
198
|
Characterization of three human apolipoprotein E isoforms (E2, E3 and E4) expressed in Escherichia coli.
|
Eur J Clin Chem Clin Biochem
|
1997
|
0.75
|
199
|
Effects of fenofibrate on hyperlipidemia and postprandial triglyceride metabolism in human apolipoprotein C1 transgenic mice.
|
Atherosclerosis
|
1998
|
0.75
|
200
|
Familial dysbetalipoproteinemia: a genetically heterogenous disease caused by mutations of the ligand apolipoprotein E.
|
J Invest Dermatol
|
1992
|
0.75
|
201
|
A novel mutation M-21V in exon 1 of the low density lipoprotein receptor gene causing familial hypercholesterolemia.
|
Clin Genet
|
1997
|
0.75
|